Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer

Figure 4

Validation of six plasma exosomal miRNAs as biomarkers for radioresistant NSCLC patients (n = 27) and radiosensitive NSCLC patients (n = 25). Expression of (a) exosomal miR-21, (b) exosomal miR-1246, (c) exosomal let-7g, (d) exosomal miR-210, (e) exosomal miR-214, and (f) exosomal miR-96 of radioresistant NSCLC patients and radiosensitive NSCLC patients. (g) The ROC curve of exosomal miR-96 in radioresistant NSCLC patients and radiosensitive NSCLC patients. RRP: radioresistant patient, RSP: radiosensitive patient.

(a)

(b)

(c)

(d)

(e)

(f)

(g)